Company intelligence / Profile preview
Cook MyoSite
Pittsburgh, Pennsylvania, United Statescookmyosite.com ↗
- Ownership
- Private
- Employees
- ~195
- Development stage
- Other
01
Overview
Cook MyoSite is currently conducting the DigniFI Study, a Phase III trial comparing iltamiocel with placebo for treating female participants with chronic fecal incontinence and obstetric anal sphincter injury. The first participant was treated on August 19, 2024.
- Therapeutic areas
- GastroenterologyWomen's HealthNephrology
- Modalities
- Cell TherapyAutologous Muscle Cell TherapiesStem Cell Therapy
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Cook MyoSite.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cook MyoSite.